Digitek Digoxin Tablet Recall

Representing Digitek / Digoxin Patients

Mark & Associates, P.C. is representing victims of Digitek (digoxin) overdose or Digitek (digoxin) toxicity due to pills containing twice the normal dose of active ingredient. Call 1-866-50-RIGHTS (1-866-507-4448) or fill out our web form for a free consultation today. Digitek (digoxin), sold under Bertek and UDL labels, and also known as Cardoxin, Digitek, Lanoxicaps or Lanoxin, was recalled in a Class I nationwide recall announced April 25, 2008. Actavis Totowa LLC (formerly known as Amide Pharmaceutical, Inc.), manufactures Digitek for distributors Mylan Pharmaceuticals Inc. and UDL Laboratories.

Double Thickness Digitek Tablets

Digitek (digoxin) is prescribed to treat heart failure and irregular heartbeat (arrhythmia). Tablets were sold with double the thickness as typical tablets, and it is suspected that these pills contained double the active ingredient. Pharmacies are currently contacting patients who may have received the double thickness pills. If you or a loved one received these defective Digitek pills and suffered an adverse side effect, please contact us today for a free legal consultation about your case. Mark & Associates, P.C. can be reached day or night by calling 1-866-50-RIGHTS (1-866-507-4448) or by filling out our online form.

Recalled Medications Include:

• Digitek
• Digoxin
• Cardoxin
• Lanoxin
• Lanoxicaps

Digitek Overdose

If you took Digitek, Cardoxin, Lanoxin or Lanoxicaps and suffered from overdose, it could be due to taking defective tablets containing twice the active ingredient as approved. Symptoms of digoxin overdose may include any of the following: nausea, vomiting, decreased appetite, diarrhea, confusion, seizures, hallucinations, light "halos" around objects, green or yellow vision, fatigue, irregular heartbeats, and abnormally fast or slow heartbeats.